2:S-1

3 trials

Sponsors

Shanghai Dongfang Department of Hepatobiliary Surgery Hospital precision Medicine Center, Shandong Cancer Hospital, Chinese PLA General Hospital

Conditions

Advanced gastric cancerBiliary tract tumorelderly esophageal cancer

Phase 2

An ambispective cohort study for apatinib versus S-1 maintenance treatment after first-line chemotherapy in advanced gastric cancer

RecruitingChiCTR1800019382

Shandong Cancer HospitalAdvanced gastric cancer

Start: 2017-11-04Updated: 2019-03-04

A prospective, open, randomized controlled trial for evaluating the safety and efficacy of oral capecitabine plus local radiotherapy for elderly patients with esophageal squamous cell carcinoma

Active, not recruitingChiCTR1900021069

Chinese PLA General Hospitalelderly esophageal cancer

Start: 2019-06-01Updated: 2019-01-28

Unknown Phase

Clinical study of apatinib mesylate treated with gemcitabine combined with platinum for treatment failure of bile duct tumor

RecruitingChiCTR1800015730

Shanghai Dongfang Department of Hepatobiliary Surgery Hospital precision Medicine CenterBiliary tract tumor

Start: 2018-04-17Updated: 2018-04-30